โ† All deals

Arcophos, Inc.

Other TechnologyAIHealthcareResearch
๐Ÿ“ San Francisco, CA, United States
StreetZero Signal 61
Be the first to signal interest

About Arcophos, Inc.

Arcophos is the frontier research lab for AI-native healthcare systems. It runs controlled experiments in clinical deployment environments to measurably improve SOTA model performance in long-horizon, non-verifiable healthcare domains. The company aims to address the critical shortage of doctors and nurses by ushering in the era of autonomous healthcare through AI-native facilities built for recursive intelligence.

LATEST FUNDINGPrivate Placement
$1.3M
Announced 2026-11-10
TOTAL RAISED$1,282,500
๐Ÿ”’

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for Arcophos, Inc..

Free plan includes 3 full deal profiles every month.

Investors

Not disclosed in the source filing. Form D filings do not list investors โ€” StreetZero surfaces them from news where available.

Key highlights

  • Operates as a frontier research lab focused on AI-native healthcare systems.
  • Conducts experiments in clinical deployment environments to advance model performance.
  • Targets autonomous healthcare facilities to address doctor and nurse shortages.
  • Raised $1.2825M via private placement with undisclosed investors.

Source document & SEC filing

The source SEC filing and the cached document are available to members only. Sign in to view and download them.

Sign in to view the filing Create free account